Search

Your search keyword '"CRLCC Oscar Lambret"' showing total 63 results

Search Constraints

Start Over You searched for: Author "CRLCC Oscar Lambret" Remove constraint Author: "CRLCC Oscar Lambret"
63 results on '"CRLCC Oscar Lambret"'

Search Results

1. Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study

2. Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial

3. Transcriptomic Analysis of Breast Cancer Stem Cells and Development of a pALDH1A1:mNeptune Reporter System for Live Tracking

4. Preclinical septic shock research: why we need an animal ICU

5. A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial

6. Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens

7. 5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study

8. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort

9. Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study

10. Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results

11. Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas

12. A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy

13. 773TiPPRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma

14. Life-Threatening Irinotecan-Induced Toxicity in an Adult Patient with Alveolar Rhabdomyosarcoma: The Role of a UGT1A1 Polymorphism

15. PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers

16. Surgically treated oesophageal cancer developed in a radiated field: Impact on peri-operative and long-term outcomes

17. Caregivers' quality of life and psychological health in response to functional, cognitive, neuropsychiatric and social deficits of patients with brain tumour: protocol for a cross-sectional study

18. Quality of Resection and Outcome in Stage III TETs: The French RYTHMIC Network Experience

19. Updated Incidence of Thymic Epithelial Tumors (TET) in France and Clinical Presentation at Diagnosis

20. New advances in DPYD genotype and risk of severe toxicity under capecitabine

21. Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

22. BRCA Share: A Collection of Clinical BRCA Gene Variants

23. Vidjil: A Web Platform for Analysis of High-Throughput Repertoire Sequencing

24. Prognostic factor analysis for elderly patients treated for metastatic colorectal cancer in the randomized phase II trial PRODIGE 20

25. Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer - PRODIGE 13 a FFCD and Unicancer phase III trial: baseline characteristics

26. Serum Proteome Analysis for Profiling Predictive Protein Markers Associated with the Severity of Skin Lesions Induced by Ionizing Radiation

27. Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study

28. Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity

29. Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study

30. Embryonal tumors with multilayered rosettes in children: the SFCE experience

31. Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

32. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats

33. Plasma ceramide, a real-time predictive marker of pulmonary and hepatic metastases response to stereotactic body radiation therapy combined with irinotecan

34. BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

35. Quand perte de sens rime avec souffrance : analyse qualitative du vécu des médecins à l’annonce d’une mauvaise nouvelle en oncologie

36. RBFOX1 Cooperates with MBNL1 to Control Splicing in Muscle, Including Events Altered in Myotonic Dystrophy Type 1

37. Intensity modulated arc therapy in bilaterally irradiated head and neck cancer: A comparative and prospective multicenter planning study

38. Régulations endogène et exogène des émotions : des processus complémentaires et indissociables

39. A French prospective pilot study for identifying dihydropyrimidine dehydrogenase (DPD) deficiency in breast cancer patients (pts) receiving capecitabine (cap)

40. Taxonomic and functional diversity of Streptomyces in a forest soil

41. Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan

42. Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: The French randomised trial ACCORD12/0405 PRODIGE 2

43. Real time bio mechanical characterization of DNA damage under therapeutic radiation beams

44. [PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved]

45. Factual understanding of randomized clinical trials: a multicenter case-control study in cancer patients

46. Nanoparticles for MRI and vascular photodynamic treatment of brain tumor

47. Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer

48. Nanoparticles for MRI and vascular photodynamic treatment of brain tumours

49. Social affiliation as a way to socially regulate emotions: Effects of others’ situational and emotional similarities

50. Evaluation de deux stratégies de régulation émotionnelle : la suppression expressive et la réévaluation cognitive

Catalog

Books, media, physical & digital resources